Stryker to Acquire Boston Scientific’s Neurovascular Business

10.28.10

Skadden is representing Stryker Corporation in its $1.5 billion acquisition of Boston Scientific Corporation’s Neurovascular business, announced on October 28.

Learn more about the practices involved

Health Care and Life Sciences ›

Mergers and Acquisitions ›

Search all news

Archive